Biotage AB (LTS:0GRP) Ending Cash Position : kr434 Mil (As of Dec. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Biotage AB Ending Cash Position?

Biotage AB's Ending Cash Position for the quarter that ended in Dec. 2024 was kr434 Mil.

Biotage AB's quarterly Ending Cash Position increased from Jun. 2024 (kr318 Mil) to Sep. 2024 (kr370 Mil) and increased from Sep. 2024 (kr370 Mil) to Dec. 2024 (kr434 Mil).

Biotage AB's annual Ending Cash Position increased from Dec. 2022 (kr441 Mil) to Dec. 2023 (kr594 Mil) but then declined from Dec. 2023 (kr594 Mil) to Dec. 2024 (kr434 Mil).

Biotage AB Ending Cash Position Historical Data

The historical data trend for Biotage AB's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotage AB Ending Cash Position Chart

Biotage AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Ending Cash Position

Get a 7-Day Free Trial

371.00

311.00

441.00

594.00

434.00

Biotage AB Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Ending Cash Position	Get a 7-Day Free Trial															594.00	683.00	318.00	370.00	434.00

Biotage AB Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Biotage AB's Ending Cash Position for the fiscal year that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	594	+	-160
	=	434

Biotage AB's Ending Cash Position for the quarter that ended in Dec. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	370	+	64
	=	434

Biotage AB Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Biotage AB's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Biotage AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biotage AB (LTS:0GRP) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

BITGF:USA BIOT:Sweden BIOTs:UK PQX1:Germany

Address

Vimpelgatan 5, Box 8, Uppsala, SWE, 751 03

Website

https://www.biotage.com

Biotage AB provides separation technology and solutions for analytical and organic chemistry from research to commercial analytical laboratories and industrial applications. Its customers span a broad range of market segments including pharmaceutical, biotech, diagnostic, contract research, and contract manufacturers as well as clinical, forensic, and academic laboratories in addition to organizations focused on food safety, clean water, and environmental sustainability. It serves three geographic markets: The Americas, APAC (Asia-Pacific,) and EMEA (Europe, Middle East & Africa). The company's product areas include Small Molecules & Synthetic Therapeutics, Biologics & Advanced Therapeutics, Scale-Up, Diagnostics, Analytical Testing, and Water & Environmental Testing.

Biotage AB Headlines

No Headlines